Caribou Biosciences Stock (NASDAQ: CRBU) stock price, news, charts, stock research, profile.
Open | $5.150 |
Close | $5.140 |
Volume / Avg. | 1.338M / 1.649M |
Day Range | 5.065 - 5.228 |
52 Wk Range | 3.440 - 8.590 |
Market Cap | $464.217M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 11.25% |
Days to Cover | 5.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Caribou Biosciences (NASDAQ: CRBU) through any online brokerage.
Other companies in Caribou Biosciences’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Inozyme Pharma (NASDAQ:INZY), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Caribou Biosciences (NASDAQ: CRBU) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 24.00 expecting CRBU to rise to within 12 months (a possible 366.93% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Caribou Biosciences (NASDAQ: CRBU) is $5.14 last updated Today at March 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Caribou Biosciences.
Caribou Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Caribou Biosciences.
Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.